Founder Securities
VC Fund
Changsha, China
Founder Securities is a Chinese company that engages in the consulting, distribution, brokerage, and management of securities business. It was founded on October 26, 1994 and is headquartered in Changsha, China
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Founder Securities invests in
Stages Founder Securities invests in
Countries Founder Securities invests in
Investment Focus
Industry
- Medical 2 (25%)
- Automotive 2 (25%)
- Health Care 2 (25%)
- Biotechnology 2 (25%)
- Service Industry 2 (25%)
Stage
- Post-IPO Equity 3 (38%)
- Series B 2 (25%)
- Series A 1 (13%)
- Series C 1 (13%)
- Series E 1 (13%)
Country
- China 7 (88%)
- United States 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Intellective Bio
|
Intellectual Bio specializes in the fields of biopharmaceutical development, commercial production, and Biologics Development. IntellectiveBio is equipped with technical platforms including Protein Science, Cell Engineering, Cell Culture, Protein Purification, Analytical Science, Formulation Development | $74.1M / Series C / Aug 04, 2022 | |
|
Huichuang Medical
|
Huichuang Medical is a neuro-imaging technique and tools developer. | Series A / Jun 02, 2022 | |
ChengTech
|
Chengtai Technology is a smart car radar R&D company specializing in the research and development of 77G millimeter wave radar technology, and is committed to providing core technology and device solutions for the wireless communication, smart car and robot industries. | $28.3M / Series B / Dec 15, 2021 | |
Han's Robot
|
Han's Robot is committed to the research and development, promotion and application of intelligent robots in the fields of industry, medical care, logistics, and services. | $61.2M / Series B / Jun 25, 2021 | |
MicuRx Pharmaceuticals
|
MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available inChina. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China. | $99.2M / Series E / Dec 21, 2020 | |
Chasing Sun Electric
|
SURPASS SUN ELECTRIC is a supplier of power and energy system solutions. | $5.3M / Post-IPO Equity / Mar 03, 2016 | |
Greatland Electrics
|
Shenzhen Greatland Electrics Inc. engages in the technical research and development of motors and control systems. | $298K / Post-IPO Equity / Dec 31, 2015 | |
Daoyoudao
|
Daoyoudao is a mobile internet marketing and industrial internet service platform. | $7.1M / Post-IPO Equity / Nov 18, 2015 |
Co-Investors
Guosen Securities
2 deals together
Zhongtai Securities
2 deals together
Addor Capital
1 deal together
Gaorong Capital
1 deal together
Changjiang Securities
1 deal together
China Baoan Group
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Founder Securities invest in?
Founder Securities invests primarily in Medical, Automotive and Health Care startups, most often at Post-IPO Equity and Series B stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Founder Securities last invest?
The most recent investment recorded for Founder Securities closed in Aug 2022. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
